FindTrial
Sign In

The ability of platelet injection in heel pain, pain in outer side of elbow and knee pain

EFFICACY OF AUTOLOGOUS PLATELET RICH PLASMA INJECTION IN PLANTAR FASCITIS, TENNIS ELBOW AND OSTEOARTHRITIS OF KNEE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049988
Enrollment
90
Registered
2023-02-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M171- Unilateral primary osteoarthritisof knee

Interventions

Intervention1: Platelet rich plasma: In this study we give 2ml intralesional injection of autologous platelet rich plasma for treatment of plantar fascitis, tennis elbow and osteoarthritis of knee and

Sponsors

Dr Vibhu Upadhyay
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i) Patients with clinically diagnosed tennis elbow, plantar fasciitis or Osteoarthritis of knee. ii) Patients should have minimum of three months duration of symptoms. iii) Patients should have undergone conservative treatment for a minimum period of three months. iv) Patients should have pain score greater than 7 at the time of PRP injection. v) Patients must not have had a local steroid injection in last 2 months. vi) Both Sexes - males and females. vii) Age- 18 years and above.

Exclusion criteria

Exclusion criteria: i) Less than 3 months duration of tennis elbow, plantar fasciitis or osteoarthritis of knee. ii) Pain score less than 7. iii) Patients without any trial of conservative treatment. iv) Patients who have Received steroid injection in past 3 months. v) Infection or ulcer at the injection site. vi) Patients with secondary osteoarthritis, Rheumatoid arthritis and Sero-negative spondyloarthritis. viii) Pregnant ladies. ix) Patients younger than 18 years. x) Suspicion of diagnosis. xi) Immunosuppressed patients. xii) Patients with connective tissue disorders. xiii) Patients with haemoglobin less than 10 mg%. xiv) Patients with tumours, metabolic bone disease.

Design outcomes

Primary

MeasureTime frame
To reduce pain in patients of osteoarthritis knee, tennis elbow and plantar fasciitisTimepoint: 36 weeks—

Secondary

MeasureTime frame
the outcome of autologous platelet rich plasma injections between plantar fasciitis, tennis elbow and osteoarthritis of knee patients.Timepoint: 1 year—

Countries

India, Malaysia

Contacts

Public ContactDR VIBHU UPADHYAY

VARUN ARJUN MEDICAL COLLEGE AND ROHILKHAND HOSPITAL , SHAHJAHANPUR, UTTAR PRADESH

Kambhure@gmail.com8176991535

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026